English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

In order to determine the necessity of creating dental medicinal products the oromucosal dosage forms of the Ukrainian pharmaceutical market have been analysed. Tablet drugs are increasingly used in the treatment of periodontal diseases. Based on the results of the analysis of 35 drugs it has been found that the share of drugs produced in Ukraine (23%) ranks second after Germany (31%) among manufacturer countries. According to the data of the marketing research 54.3% of solid dosage forms are tablets, 25.7% – lozenges and 20% – pastilles. It has been determined that 34.3% of drugs are two-component products, 25.7% – three-component, 20% are one-component and 20% are multi-component. Distinguishing the concept of active substances it has been shown that 77.1% of drugs contain antiseptics, 14.3% – antibiotics, 20% – essential oils, 17.1% – anesthetics. Natural substances as a component are in 8.6% of medicinal products, e.g. phenolic hydrophobic propolis preparation in “Proalor” (LLC “Pharmaceutical company “Zdorovie”, Ukraine), a thick sage extract in “Shavlia” (Natur Product Europa BV, Netherlands) and a solid chlorophyllipt extract in “Chlorophyllipt” tablets (LLC “Pilot Plant “State Scientific Centre on Medicinal Products”, Ukraine). It has been found that there is dominance of combined drugs and a small share of drugs based on natural substances; therefore, creation of oromucosal herbal medicinal products in a solid dosage form is expedient.

Analysis of oromucosal medicinal products in solid dosage forms for therapeutic dentistry